drugset / Trial / NCT00195806

Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatment of Adolescents With Migraine

NCT00195806

Phase 3 Completed 315 enrolled Abbott
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if long-term treatment, up to 1 year, with Depakote ER is safe in the reduction of occurrence of migraine headaches in adolescents.

Timeline

Start
2005-02
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Divalproex Sodium Small molecule

Indications